<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The use of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells as vaccines in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> immunotherapy is critically dependent on their capacity to initiate and amplify <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-specific immunity </plain></SENT>
<SENT sid="1" pm="."><plain>Optimal responses may require the modification of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells not only to increase their immunogenicity but also to improve their ability to recruit effector cells to the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> sites or sites of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> antigen exposure </plain></SENT>
<SENT sid="2" pm="."><plain>It has been reported that CD40 cross-linking of <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) cells significantly increases their immunogenicity and allows the generation and expansion of autologous antileukemia cytotoxic T lymphocytes </plain></SENT>
<SENT sid="3" pm="."><plain>This study demonstrates that the CD40 ligation of these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells also induces the secretion of the CC-chemokines MDC and TARC </plain></SENT>
<SENT sid="4" pm="."><plain>Supernatants from malignant cells cultured in the presence of sCD40L promote the migration of activated T cells that express CCR4, the common specific receptor for MDC and TARC </plain></SENT>
<SENT sid="5" pm="."><plain>More importantly, the supernatants from CD40-stimulated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells also support the transendothelial migration of autologous CCR4(+) antileukemia T cells </plain></SENT>
<SENT sid="6" pm="."><plain>Therefore, the results demonstrate that the delivery to <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells of a single physiologic signal, that is, CD40 cross-linking, simultaneously improves <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell immunogenicity and induces potent chemoattraction for T cells </plain></SENT>
<SENT sid="7" pm="."><plain>(Blood </plain></SENT>
<SENT sid="8" pm="."><plain>2001;98:533-540) </plain></SENT>
</text></document>